By Counterforce Health Team in Helixate (antihemophilic factor, rFVIII) —

How to Get Helixate (antihemophilic factor, rFVIII) Covered by Aetna CVS Health in Ohio: Complete Prior Authorization and Appeals Guide 2024

Quick Answer: Getting Helixate (antihemophilic factor, rFVIII) Covered by Aetna CVS Health in Ohio

Aetna CVS Health requires prior authorization for Helixate (antihemophilic factor, rFVIII) in Ohio. Submit your PA request through your hematologist with complete hemophilia A documentation, including factor VIII levels <1% (severe) or 1-5% (moderate), bleed history, and inhibitor status. Submit via Aetna's provider portal or fax to 1-855-734-9389 for Aetna Better Health Ohio (Medicaid). Standard decisions take 10 calendar days; urgent requests get 48-hour review. If denied, you have 180 days to appeal internally, then request external review through the Ohio Department of Insurance.

Table of Contents

  1. Understanding Helixate Availability and Alternatives
  2. Aetna CVS Health Coverage Requirements
  3. Step-by-Step Prior Authorization Process
  4. Medical Necessity Documentation
  5. Common Denial Reasons and Solutions
  6. Appeals Process in Ohio
  7. Peer-to-Peer Review Strategy
  8. Ohio External Review Process
  9. Cost Assistance Options
  10. Frequently Asked Questions

Understanding Helixate Availability and Alternatives

Important Update: Helixate FS (CSL Behring) was discontinued in the US after December 2017, with supply available through early 2019. Kogenate FS (Bayer) was also discontinued in the US, with larger vials depleted by fall 2022.

If you're seeking coverage for what was previously Helixate or Kogenate FS, your hematologist will need to prescribe an alternative recombinant factor VIII product:

Primary Alternatives:

  • Kovaltry (standard half-life, suitable for all ages)
  • Jivi (extended half-life PEGylated, ages 12+)
  • Afstyla (single-chain recombinant factor VIII)
  • Eloctate (extended half-life)
Note: Do not switch factor products without hematologist guidance due to potential allergy risks and different dosing requirements.

Aetna CVS Health Coverage Requirements

Aetna CVS Health requires prior authorization for all recombinant factor VIII products across their Ohio plans, including commercial, Aetna Better Health Ohio (Medicaid), and Medicare products.

Coverage at a Glance

Requirement Details Source
Prior Authorization Required for all factor VIII concentrates Aetna Precertification List 2025
Prescriber Must be hematologist or hemophilia treatment center Aetna Clinical Policy
Diagnosis Confirmed hemophilia A with factor VIII deficiency Aetna Medical Necessity Criteria
Lab Requirements Factor VIII activity levels, inhibitor testing Aetna Clinical Policy
Decision Timeline 10 calendar days standard, 48 hours urgent Aetna Better Health Ohio

Step-by-Step Prior Authorization Process

Step 1: Verify Coverage and PA Requirements

  • Check your member ID card for plan type
  • Confirm current PA requirements on Aetna's precertification list
  • For Aetna Better Health Ohio (Medicaid), verify eligibility first

Step 2: Gather Required Documentation

Essential Documents:

  • Complete Aetna PA request form
  • Hematologist's medical necessity letter
  • Recent factor VIII activity levels
  • Inhibitor testing results
  • Bleed history documentation
  • Prior therapy records

Step 3: Submit Your Request

Submission Options:

  • Aetna Provider Portal: Log in through Aetna's provider portal
  • Availity/Novologix: Use for faster processing (95%+ approvals within 24 hours when eligible)
  • Fax: Aetna Better Health Ohio: 1-855-734-9389

Step 4: Track Your Request

  • Monitor status through provider portal
  • Standard decisions: 10 calendar days
  • Urgent decisions: 48 hours
  • Request peer-to-peer review if initial review raises questions

Medical Necessity Documentation

Your hematologist's letter must include specific clinical criteria to meet Aetna's medical necessity requirements:

Required Clinical Information

Diagnosis Documentation:

  • ICD-10 code D66 (hereditary factor VIII deficiency)
  • Factor VIII activity level: <1% (severe) or 1-5% (moderate)
  • Genetic testing confirmation if available

Treatment History:

  • Previous factor VIII products used
  • Response to prior therapies
  • Reasons for switching (if applicable)
  • Desmopressin trial results (for mild/moderate cases)

Current Clinical Status:

  • Recent bleed frequency and severity
  • Joint damage assessment
  • Inhibitor status (<5 BU/mL for non-bypassing agents)
  • Target trough levels for prophylaxis
Clinician Corner: Include weight-based dosing calculations and cite MASAC guidelines for prophylaxis recommendations to strengthen medical necessity.

Common Denial Reasons and Solutions

Denial Reason Solution Strategy
Non-formulary product Request formulary exception with medical necessity documentation; cite discontinued status of Helixate/Kogenate FS
Missing inhibitor status Submit recent Bethesda assay results; explain timing of testing relative to factor exposure
Insufficient prior therapy documentation Provide detailed records of previous treatments, including dates, doses, and outcomes
"Not medically necessary" Include bleed logs, joint assessments, and cite prophylaxis guidelines for severe hemophilia A
Experimental/investigational Submit FDA approval documentation and peer-reviewed efficacy studies

Appeals Process in Ohio

If your initial PA request is denied, you have multiple appeal options:

Internal Appeals with Aetna CVS Health

  • Timeline: Submit within 180 days of denial notice
  • Standard appeal: Decision within 30 days
  • Expedited appeal: Decision within 72 hours for urgent medical needs
  • Submit to: Use same channels as initial PA request

Required Appeal Documentation

  • Copy of original denial letter
  • Updated medical necessity letter addressing denial reasons
  • Any new clinical evidence
  • Request for peer-to-peer review

Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals by analyzing denial letters and plan policies to draft point-by-point rebuttals aligned with the payer's own rules.

Peer-to-Peer Review Strategy

Aetna's peer-to-peer review process allows your hematologist to discuss your case directly with an Aetna physician reviewer:

How to Request

  • Include peer-to-peer request with your appeal
  • Contact Aetna customer service to schedule
  • Prepare clinical talking points in advance

Key Discussion Points

  • Severity of hemophilia A and bleeding risk
  • Prior therapy failures or contraindications
  • Prophylaxis goals and target trough levels
  • Quality of life and functional outcomes
From our advocates: "We've seen peer-to-peer reviews turn around denials when the prescribing hematologist can explain why standard formulary alternatives won't work—whether due to previous allergic reactions, poor response, or specific dosing requirements that only the requested product can meet."

Ohio External Review Process

If Aetna upholds their denial after internal appeals, Ohio law provides an independent external review option:

Eligibility and Timeline

  • Must exhaust Aetna's internal appeals first
  • Submit request within 180 days of final denial
  • Submit written request to Aetna, who forwards to Ohio Department of Insurance

External Review Process

  • Standard review: Decision within 30 days
  • Expedited review: Decision within 72 hours (for urgent medical conditions)
  • Independent Review Organization (IRO) conducts medical review
  • Decision is binding on Aetna

Ohio Department of Insurance Resources

Cost Assistance Options

Even with insurance coverage, factor concentrates can have significant copays:

Manufacturer Support Programs

  • Check with current factor VIII manufacturer for copay assistance
  • Most programs reduce monthly costs to $5-$25
  • Income limits may apply

Patient Assistance Foundations

  • National Hemophilia Foundation
  • Hemophilia Federation of America
  • State-specific hemophilia organizations in Ohio

Ohio Medicaid

  • Aetna Better Health Ohio covers factor concentrates
  • No copays for eligible members
  • Must meet income and asset requirements

Frequently Asked Questions

How long does Aetna CVS Health prior authorization take in Ohio? Standard PA decisions take 10 calendar days; urgent requests are processed within 48 hours.

What if my requested factor VIII product is non-formulary? Request a formulary exception with medical necessity documentation. Aetna approves over 95% of eligible prior authorizations when properly documented.

Can I request an expedited appeal in Ohio? Yes, if your condition poses serious risk to health. Expedited appeals must be decided within 72 hours.

Does step therapy apply if I've used factor VIII products outside Ohio? Submit documentation of prior therapy from any state. Aetna recognizes out-of-state treatment history.

What happens if I run out of factor during the appeal process? Contact your hemophilia treatment center immediately. They may provide emergency supplies or help expedite your appeal.

Can my pharmacy help with the prior authorization? CVS Specialty Pharmacy coordinates with Aetna for specialty medications and can assist with PA submissions.

How do I know if my appeal was successful? Aetna will send written notification. You can also check status through their provider portal or by calling member services.

What if I disagree with the external review decision? External review decisions are binding, but you retain the right to pursue other legal remedies if appropriate.

This information is for educational purposes only and does not constitute medical or legal advice. Coverage decisions depend on individual circumstances and plan terms. For personalized assistance with complex appeals, consider consulting with specialists like Counterforce Health, who help patients and clinicians navigate insurance denials with evidence-based appeal strategies.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.